107 related articles for article (PubMed ID: 19179323)
1. Getting to the heart of proteomics.
Ping P
N Engl J Med; 2009 Jan; 360(5):532-4. PubMed ID: 19179323
[No Abstract] [Full Text] [Related]
2. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart.
Chen CH; Budas GR; Churchill EN; Disatnik MH; Hurley TD; Mochly-Rosen D
Science; 2008 Sep; 321(5895):1493-5. PubMed ID: 18787169
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models.
Contractor H; Støttrup NB; Cunnington C; Manlhiot C; Diesch J; Ormerod JO; Jensen R; Bøtker HE; Redington A; Schmidt MR; Ashrafian H; Kharbanda RK
Basic Res Cardiol; 2013 May; 108(3):343. PubMed ID: 23525499
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?
Budas GR; Disatnik MH; Mochly-Rosen D
Trends Cardiovasc Med; 2009 Jul; 19(5):158-64. PubMed ID: 20005475
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen plays a permissive role in cardioprotection.
Cohen MV; Downey JM
Cardiovasc Res; 2008 Aug; 79(3):353-4. PubMed ID: 18539628
[No Abstract] [Full Text] [Related]
6. [Anti-apoptotic role of mitochondrial aldehyde dehydrogenase 2 in myocardial ischemia/reperfusion injury in diabetic rats].
Wang HJ; Kang PF; Ye HW; Yu Y; Wang XM; Gao Q
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):345-8. PubMed ID: 22445980
[TBL] [Abstract][Full Text] [Related]
7. Delayed preconditioning by sevoflurane elicits changes in the mitochondrial proteome in ischemia-reperfused rat hearts.
Xiao YY; Chang YT; Ran K; Liu JP
Anesth Analg; 2011 Aug; 113(2):224-32. PubMed ID: 21659557
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury.
Gong D; Zhang Y; Zhang H; Gu H; Jiang Q; Hu S
Cardiovasc Toxicol; 2012 Dec; 12(4):350-8. PubMed ID: 22814936
[TBL] [Abstract][Full Text] [Related]
9. Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway.
Xiao Y; Chen W; Zhong Z; Ding L; Bai H; Chen H; Zhang H; Gu Y; Lu S
Biomed Pharmacother; 2020 Jul; 127():110148. PubMed ID: 32344255
[TBL] [Abstract][Full Text] [Related]
10. Signalling during an ischaemic preconditioning protocol: new role players?
Lochner A
Cardiovasc Res; 2011 Apr; 90(1):5-6. PubMed ID: 21307089
[No Abstract] [Full Text] [Related]
11. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
Yadav HN; Singh M; Sharma PL
Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
[TBL] [Abstract][Full Text] [Related]
13. No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning.
Totzeck A; Boengler K; van de Sand A; Konietzka I; Gres P; Garcia-Dorado D; Heusch G; Schulz R
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2106-12. PubMed ID: 18835920
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
15. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J
Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C activation and cardioprotective effect of preconditioning with oxidative stress in isolated rat heart.
Sharma A; Singh M
Mol Cell Biochem; 2001 Mar; 219(1-2):1-6. PubMed ID: 11354240
[TBL] [Abstract][Full Text] [Related]
17. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Bencsik P; Kupai K; Giricz Z; Görbe A; Pipis J; Murlasits Z; Kocsis GF; Varga-Orvos Z; Puskás LG; Csonka C; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H512-8. PubMed ID: 20543091
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection.
Gong D; Zhang H; Hu S
J Mol Cell Cardiol; 2013 Feb; 55():58-63. PubMed ID: 22507541
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
Kocsis GF; Pipis J; Fekete V; Kovács-Simon A; Odendaal L; Molnár E; Giricz Z; Janáky T; van Rooyen J; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2406-9. PubMed ID: 18359895
[TBL] [Abstract][Full Text] [Related]
20. Reduced susceptibility to ischemia-induced arrhythmias in the preconditioned rat heart is independent of PI3-kinase/Akt.
Ravingerova T; Matejikova J; Pancza D; Kolar F
Physiol Res; 2009; 58(3):443-447. PubMed ID: 19627174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
